Importer of Controlled Substances Application: Curia Wisconsin, Inc., 94762-94763 [2024-28063]
Download as PDF
<![CDATA[
94762
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
completed and filed its determinations
in these reviews on November 22, 2024.
The views of the Commission are
contained in USITC Publication 5564
(November 2024), entitled Glycine from
China, India, Japan, and Thailand:
Investigation Nos. 701–TA–603–604 and
731–TA–1413–1415 (Review).
By order of the Commission.
Issued: November 22, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–28018 Filed 11–27–24; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–739–740 and
731–TA–1716–1717 (Preliminary)]
Thermoformed Molded Fiber Products
From China and Vietnam
Determinations
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that there is a reasonable indication that
an industry in the United States is
materially injured by reason of imports
of thermoformed molded fiber products
(‘‘TMFPs’’) from China and Vietnam,
provided for in subheading 4823.70.00
of the Harmonized Tariff Schedule of
the United States, that are alleged to be
sold in the United States at less than fair
value (‘‘LTFV’’) and imports of the
subject merchandise from China and
Vietnam that are alleged to be
subsidized by the governments of China
and Vietnam.2
khammond on DSK9W7S144PROD with NOTICES
Commencement of Final Phase
Investigations
Pursuant to section 207.18 of the
Commission’s rules, the Commission
also gives notice of the commencement
of the final phase of its investigations.
The Commission will issue a final phase
notice of scheduling, which will be
published in the Federal Register as
provided in § 207.21 of the
Commission’s rules, upon notice from
the U.S. Department of Commerce
(‘‘Commerce’’) of affirmative
preliminary determinations in the
investigations under §§ 703(b) or 733(b)
of the Act, or, if the preliminary
determinations are negative, upon
notice of affirmative final
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 89 FR 87551 and 87556 (November 4, 2024).
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
determinations in those investigations
under §§ 705(a) or 735(a) of the Act.
Parties that filed entries of appearance
in the preliminary phase of the
investigations need not enter a separate
appearance for the final phase of the
investigations. Any other party may file
an entry of appearance for the final
phase of the investigations after
publication of the final phase notice of
scheduling. Industrial users, and, if the
merchandise under investigation is sold
at the retail level, representative
consumer organizations have the right
to appear as parties in Commission
antidumping and countervailing duty
investigations. The Secretary will
prepare a public service list containing
the names and addresses of all persons,
or their representatives, who are parties
to the investigations. As provided in
section 207.20 of the Commission’s
rules, the Director of the Office of
Investigations will circulate draft
questionnaires for the final phase of the
investigations to parties to the
investigations, placing copies on the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov), for comment.
Background
On October 8, 2024, the American
Molded Fiber Coalition, which is
comprised of Genera Inc., Vonore,
Tennessee; Tellus Products, LLC, Belle
Glade, Florida; and the United Steel,
Paper and Forestry, Rubber,
Manufacturing, Energy, Allied
Industrial and Service Workers
International Union, AFL–CIO, filed
petitions with the Commission and
Commerce, alleging that an industry in
the United States is materially injured
or threatened with material injury by
reason of subsidized imports of TMFPs
from China and Vietnam and LTFV
imports of TMFPs from China and
Vietnam. Accordingly, effective October
8, 2024, the Commission instituted
countervailing duty investigation Nos.
701–TA–739–740 and antidumping
duty investigation Nos. 731–TA–1716–
1717 (Preliminary).
Notice of the institution of the
Commission’s investigations and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register on October 15, 2024
(89 FR 83051). The Commission
conducted its conference on October 29,
2024. All persons who requested the
opportunity were permitted to
participate.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
The Commission made these
determinations pursuant to §§ 703(a)
and 733(a) of the Act (19 U.S.C.
1671b(a) and 1673b(a)). It completed
and filed its determinations in these
investigations on November 22, 2024.
The views of the Commission are
contained in USITC Publication 5568
(December 2024), entitled
Thermoformed Molded Fiber Products
from China and Vietnam: Investigation
Nos. 701–TA–739–740 and 731–TA–
1716–1717 (Preliminary).
By order of the Commission.
Issued: November 22, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–27937 Filed 11–27–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1448]
Importer of Controlled Substances
Application: Curia Wisconsin, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia Wisconsin, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 30, 2024. Such
persons may also file a written request
for a hearing on the application on or
before December 30, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 22, 2024, Curia
Wisconsin, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024–9436,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled substance
Gamma Hydroxybutyric Acid.
Marihuana Extract ....
Marihuana .................
Dimethyltryptamine ...
Drug
code
Schedule
2010
I
7350
7360
7435
I
I
I
The company plans to import the
listed controlled substances for
analytical testing or distribution. No
other activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–28063 Filed 11–27–24; 8:45 am]
BILLING CODE P
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 30, 2024. Such
persons may also file a written request
for a hearing on the application on or
before December 30, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 18, 2024, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
DATES:
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
Psilocybin ........................
4-Anilino-N-phenethyl-4piperidine (ANPP).
Phenylacetone .................
Coca Leaves ...................
Opium Raw ......................
Poppy Straw Concentrate
[Docket No. DEA–1460]
Importer of Controlled Substances
Application: Cambrex Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
khammond on DSK9W7S144PROD with NOTICES
AGENCY:
Cambrex Charles City has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
SUMMARY:
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
Drug
code
Schedule
7437
8333
I
II
8501
9040
9600
9670
II
II
II
II
The company plans to import
psilocybin for formulation development
and clinical trial support for their
customers. The remaining listed
controlled substances will be imported
to support the manufacture into other
controlled substances which will be
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
94763
distributed to their customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–28064 Filed 11–27–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0059]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Previously Approved Collection;
Registration for Controlled Substances
Act Data-Use Request
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 30, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Heather E. Achbach, Regulatory
Drafting and Policy Support Section,
Drug Enforcement Administration;
Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152;
Telephone: (571) 776–3882; Email:
DEA.PRA@dea.gov or
Heather.E.Achbach@dea.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 24, 2024, at 89
FR 77895, allowing for a 60-day
comment period. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94762-94763]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28063]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1448]
Importer of Controlled Substances Application: Curia Wisconsin,
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Wisconsin, Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 30, 2024. Such persons may also file a written request for a
hearing on the application on or before December 30, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
[[Page 94763]]
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 22, 2024, Curia Wisconsin, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024-9436, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............. 2010 I
Marihuana Extract..................... 7350 I
Marihuana............................. 7360 I
Dimethyltryptamine.................... 7435 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
analytical testing or distribution. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-28063 Filed 11-27-24; 8:45 am]
BILLING CODE P
